TCM
TMO icon

Triumph Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Triumph Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
439
+5
+1% +$2.4K 0.04% 339
2026
Q1 		$214K Buy
434
+3
+0.7% +$1.63K 0.04% 325
2025
Q4 		$250K Sell
431
-32
-7% -$18.1K 0.05% 277
2025
Q3 		$225K Sell
463
-223
-33% -$104K 0.06% 287
2025
Q2 		$278K Sell
686
-133
-16% -$55.6K 0.08% 233
2025
Q1 		$408K Sell
819
-1
-0.1% -$542 0.14% 179
2024
Q4 		$427K Sell
820
-143
-15% -$78.6K 0.15% 169
2024
Q3 		$596K Buy
963
+143
+17% +$84.7K 0.21% 123
2024
Q2 		$454K Sell
820
-3
-0.4% -$1.72K 0.18% 135
2024
Q1 		$475K Sell
823
-150
-15% -$84.2K 0.19% 118
2023
Q4 		$517K Sell
973
-94
-9% -$45.5K 0.22% 96
2023
Q3 		$540K Sell
1,067
-106
-9% -$56.5K 0.25% 96
2023
Q2 		$612K Buy
1,173
+40
+4% +$21.6K 0.28% 77
2023
Q1 		$653K Sell
1,133
-450
-28% -$254K 0.33% 58
2022
Q4 		$872K Sell
1,583
-580
-27% -$307K 0.47% 42
2022
Q3 		$1.1M Buy
2,163
+236
+12% +$132K 0.6% 39
2022
Q2 		$1.05M Sell
1,927
-172
-8% -$94.7K 0.55% 43
2022
Q1 		$1.24M Buy
+2,099
New +$1.21M 0.54% 40

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Triumph Capital Management's TMO Position: Q2 2026 in Review

Triumph Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, buying an estimated $2.4K and bringing the position to 439 shares worth $220K. The position accounts for 0.04% of the portfolio, ranked #339.

Triumph Capital Management first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.24M in Q1 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Triumph Capital Management held 439 shares of Thermo Fisher Scientific worth $220K as of Q2 2026.
  • Triumph Capital Management bought 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.04% of Triumph Capital Management's portfolio in Q2 2026, its #339 holding.
  • Triumph Capital Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • Triumph Capital Management's Thermo Fisher Scientific position peaked at $1.24M in Q1 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.